AUSTRALIA'S #1 ONLINE CPD EDUCATION PLATFORM

Do you consider the quality of life impacts for your patients with psoriasis? This webinar will cover the background to adult psoriasis in Australia, how to do a practical assessment of psoriasis severity, and...
In this webinar, A/Prof Ralph Audehm and senior practice nurse Shereen Faiyaz will take you through how their GP practices conduct a best-practice recall and review of their patients with T2D, using a whole-of...
Join us as leading dermatologist, Clinical Professor Saxon Smith AM, discusses prevention, diagnosis, and management of common non-melanoma skin conditions such as solar keratosis, BCC, Bowen’s disease, SCC...
This two-part activity provides education on the various long-acting buprenorphine formulations available in Australia, followed by a practical exercise where the learner goes through the steps of assessing...
In this clinical audit, you will conduct Heart Health Checks for your patients, providing comprehensive cardiovascular risk assessments and developing ongoing management plans involving pharmacological and...

This clinical audit aims to improve the management of patients with iron deficiency following oral or IV iron supplementation.

Ensuring a patient-centred approach to care for people living with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)

Module 2 of a 2-part series: Providing care for people with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) requires a patient-centred approach with a focus on quality of life and incorporating the multidisciplinary team. This second module on ME/CFS provides detail on making a differential diagnosis, the non-core symptoms of ME/CFS, management in specific populations, and the development of a patient-centred treatment plan.

IN Control clinical audit: INsulin INitiation and INtensification to avoid clinical INertia

Timely intensification of glucose-lowering medications to achieve target HbA1c is a key aspect of type 2 diabetes management. This program aims to support initiation or intensification of insulin therapy for patients who are currently not at their target HbA1c.

Dementia in diverse groups - On-demand webinar

As in many therapeutic areas, cultural and linguistic diversity has an impact on the recognition, diagnosis and management of dementia -- but the ‘how’, ‘why’ and ‘what to do’ for people with dementia in diverse groups can be tricky to navigate in busy primary practice. This activity explores the different clinical presentations of dementia in diverse populations, as well as the social, family and other considerations relevant to people in cultural and linguistically diverse (CALD) groups.

T2D injectables: 1. Intensifying to first injectable therapy in uncomplicated type 2 diabetes

This education module focuses on a case study of an uncomplicated patient with type 2 diabetes, and the process of intensifying to first injectable therapy. Expert video commentary throughout the module helps step the participant through the decision cycle from the ADA/EASD consensus guidelines for T2D. This module also includes Australian recommendations for patients fasting during Ramadan.

T2D injectables: 2. Intensifying to first injectable therapy in patients with ASCVD risk

In this education module, the participant will work through a case study of a type 2 diabetes patient with ASCVD risk factors. The case study uses the decision cycle from the ADA/EASD consensus guidelines for T2D, and features expert video commentary. The module also discusses patient-related concerns leading to clinical inertia, including useful management decisions when faced with this issue.

T2D injectables: 3. Intensifying to first injectable therapy in patients with established ASCVD

This education module takes a case-study based look at the management of a type 2 diabetes patient with established ASCVD. Featuring expert video commentary, participants will use the decision cycle from the ADA/EASD consensus guidelines for T2D to work through a hypothetical case study. This module also discusses GP-related causes of clinical inertia, as well as additional patient factors such as obesity, low health literacy and diabetes distress.

Pages